Nami Lee

440 total citations
15 papers, 323 citations indexed

About

Nami Lee is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nami Lee has authored 15 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nami Lee's work include Liver Disease Diagnosis and Treatment (7 papers), Diabetes Treatment and Management (4 papers) and Pancreatitis Pathology and Treatment (3 papers). Nami Lee is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Diabetes Treatment and Management (4 papers) and Pancreatitis Pathology and Treatment (3 papers). Nami Lee collaborates with scholars based in South Korea and United States. Nami Lee's co-authors include Seung Jin Han, Dae Jung Kim, Kwan Woo Lee, Hae Jin Kim, Ja Young Jeon, Yup Kang, Sung‐E Choi, Yu Jung Heo, Kyoung Hwa Ha and Young‐Min Ye and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Nami Lee

15 papers receiving 319 citations

Peers

Nami Lee

EDM

SURGE

EPIDE

IMMUN

Elisabetta L. Romeo Italy

Takamasa Nishiuchi Japan

Marcel G. M. Wolfs Netherlands

Warangkana Pichaiwong Thailand

Han-Seong Kim South Korea

Dorothée Thuillier France

Zhang Lin China

H. Carlijne Hassing Netherlands

Meifang Gao China

Yujie Zhou China

Elisabetta L. Romeo Italy

Nami Lee

141 ×1.1

EDM

152 ×1.7

63 ×0.9

SURGE

52 ×0.7

EPIDE

46 ×1.0

IMMUN

Citations per year, relative to Nami Lee Nami Lee (= 1×) peers Elisabetta L. Romeo

Countries citing papers authored by Nami Lee

Since Specialization

Citations

This map shows the geographic impact of Nami Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nami Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nami Lee more than expected).

Fields of papers citing papers by Nami Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nami Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nami Lee. The network helps show where Nami Lee may publish in the future.

Co-authorship network of co-authors of Nami Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Nami Lee. A scholar is included among the top collaborators of Nami Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nami Lee. Nami Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Heo, Yu Jung, Nami Lee, Sung-E Choi, et al.. (2025). Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 26(9). 4054–4054. 1 indexed citations

Heo, Yu Jung, Nami Lee, Sung‐E Choi, et al.. (2024). Cysteine‐rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high‐fat diet fed mice and HepG2 cells. The FASEB Journal. 38(15). 2 indexed citations

Jeon, Ja Young, Nami Lee, Hae Jin Kim, et al.. (2023). Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients. Endocrinology and Metabolism. 38(1). 139–145. 6 indexed citations

Heo, Yu Jung, Nami Lee, Sung‐E Choi, et al.. (2023). Amphiregulin Induces iNOS and COX-2 Expression through NF-κB and MAPK Signaling in Hepatic Inflammation. Mediators of Inflammation. 2023. 1–11. 15 indexed citations

Heo, Yu‐Jung, Hae Jin Kim, Nami Lee, et al.. (2023). 1519-P: Role of Cyr61 in Palmitic Acid-Induced Insulin Resistance and Inflammation in Hepatocyte. Diabetes. 72(Supplement_1). 1 indexed citations

Lee, Nami, Ja Young Jeon, Hae Jin Kim, et al.. (2022). Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study. Diabetes Care. 45(5). 1141–1150. 11 indexed citations

Lee, Nami, Sung‐E Choi, Ja‐Young Jeon, et al.. (2022). Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway. Biomedicines. 10(5). 1032–1032. 15 indexed citations

Lee, Nami, Yu Jung Heo, Sung‐E Choi, et al.. (2021). Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease. Biochemical and Biophysical Research Communications. 588. 154–160. 18 indexed citations

Lee, Nami, Yu Jung Heo, Sung‐E Choi, et al.. (2021). Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways. Journal of Immunology Research. 2021. 1–11. 97 indexed citations

10.

Heo, Yu Jung, Sung‐E Choi, Nami Lee, et al.. (2021). Visfatin exacerbates hepatic inflammation and fibrosis in a methionine‐choline‐deficient diet mouse model. Journal of Gastroenterology and Hepatology. 36(9). 2592–2600. 22 indexed citations

11.

Lee, Nami, et al.. (2020). Reduction of visceral fat could be related to the improvement of TBS in diabetes mellitus. Journal of Bone and Mineral Metabolism. 38(5). 702–709. 16 indexed citations

12.

Heo, Yu Jung, Sung‐E Choi, Nami Lee, et al.. (2020). CCL20 induced by visfatin in macrophages via the NF-κB and MKK3/6-p38 signaling pathways contributes to hepatic stellate cell activation. Molecular Biology Reports. 47(6). 4285–4293. 15 indexed citations

13.

Lee, Nami, Yong Jun Choi, & Yoon‐Sok Chung. (2020). The secular trends in the use of medications for osteoporosis in South Korea using Intercontinental Medical Statistics Health Sales Audit 2006–2018. SHILAP Revista de lepidopterología. 6(4). 185–190. 7 indexed citations

14.

Han, Seung Jin, Kyoung Hwa Ha, Nami Lee, & Dae Jung Kim. (2020). Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: A nationwide population‐based study. Diabetes Obesity and Metabolism. 23(3). 682–691. 59 indexed citations

15.

Lee, Nami, Jeong-Dong Lee, Hyun Young Lee, Dae Ryong Kang, & Young‐Min Ye. (2017). Epidemiology of Chronic Urticaria in Korea Using the Korean Health Insurance Database, 2010-2014. Allergy Asthma and Immunology Research. 9(5). 438–438. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact